Cargando…
Downfalls of Chemical Probes Acting at the Kinase ATP-Site: CK2 as a Case Study
Protein kinases are a large class of enzymes with numerous biological roles and many have been implicated in a vast array of diseases, including cancer and the novel coronavirus infection COVID-19. Thus, the development of chemical probes to selectively target each kinase is of great interest. Inhib...
Autores principales: | Atkinson, Eleanor L., Iegre, Jessica, Brear, Paul D., Zhabina, Elizabeth A., Hyvönen, Marko, Spring, David R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037657/ https://www.ncbi.nlm.nih.gov/pubmed/33807474 http://dx.doi.org/10.3390/molecules26071977 |
Ejemplares similares
-
Development of small cyclic peptides targeting the CK2α/β interface
por: Atkinson, Eleanor L., et al.
Publicado: (2022) -
Novel non-ATP competitive small molecules targeting the CK2 α/β interface
por: Brear, Paul, et al.
Publicado: (2018) -
A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066
por: De Fusco, Claudia, et al.
Publicado: (2017) -
A fragment-based approach leading to the discovery of inhibitors of CK2α with a novel mechanism of action
por: Brear, Paul, et al.
Publicado: (2022) -
Efficient development of stable and highly functionalised peptides targeting the CK2α/CK2β protein–protein interaction
por: Iegre, Jessica, et al.
Publicado: (2019)